Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. has announced that Global Growth Holding Limited has converted three bonds from the fourth tranche of its reserved convertible bond with warrants, at a price of €0.02 per share, into 1,500,000 new Fidia shares. These new shares are immediately admitted to trading on the regulated market under the company’s existing prospectus, further progressing the structured financing plan approved in early 2026.
Following this conversion, the POC has reached a total nominal subscription of €1,000,000, with €840,000 of the related capital increase already executed and 16 bonds still outstanding. As a result, Fidia’s share capital rises by €30,000 to €10,687,761.90 and the total number of shares increases to 45,042,927, implying incremental equity dilution but also reinforcing the company’s capital base to support its industrial and market objectives.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of high-performance integrated milling systems and numerical controls. The group focuses on complex-shape machining for the automotive molds segment and the aerospace sector, offering end-to-end solutions from machining program definition to finished product through hardware, software and global support services.
Average Trading Volume: 1,291,977
Technical Sentiment Signal: Strong Sell
Current Market Cap: €908.7K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.